Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/22/2012 | US20120070382 Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof |
03/22/2012 | US20120070374 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides |
03/22/2012 | US20120067744 Impurity Detection Device and Method |
03/22/2012 | US20120067742 Linker, impedance biochip, and method of quantitatively detecting target analyte in fluid sample using the biochip |
03/22/2012 | US20120067723 Temperature Control of Chemical Detection System |
03/22/2012 | US20120067722 Biosensor for measuring biomaterial |
03/22/2012 | US20120067370 Semi-automated heat exchanger tube cleaning assembly and method |
03/22/2012 | US20120067111 Bearing, arrangement for determining properties of a lubricant in a bearing and method for determining properties of a lubricant in a bearing |
03/22/2012 | US20120066875 Method and system for grading bedding fabric |
03/22/2012 | DE102010047283B4 Untersuchungsverfahren/Screeningverfahren unter Einbeziehung von lebenden Geweben des Blutgefäß-Systems Investigation procedure / screening processes involving living tissues of the vascular system |
03/22/2012 | DE102010046912A1 Verfahren zum Nachweis von fettlöslichen Vitaminen A method for the detection of fat-soluble vitamins |
03/22/2012 | DE102010046047A1 Substanz zur gerichtsverwertbaren Markierung Substance to be used in court marking |
03/22/2012 | DE102010045599A1 Method for rapid test of neuroborreliosis, comprises dripping fluid from cerebrospinal fluid to a portion of a test strip and subsequently reading an optical indicator in a different section of the test strip |
03/22/2012 | DE102010041166A1 Sensoranordnung Sensor array |
03/22/2012 | DE102010037578A1 Device for measuring mechanical properties of viscoelastic sample i.e. vital soft tissue, of internal organ, has measuring head securely held at sample by fixator even when maximum permissible pressure is applied to measuring chamber |
03/22/2012 | DE102009043537B4 Verfahren und Anordnung zur Bestimmung von Zell-Vitalitäten Method and apparatus for determining cell viabilities |
03/22/2012 | DE102009041885B4 Separation von Mesenchymalen Stammzellen Mesenchymal stem cells separation of |
03/22/2012 | DE102008012760B4 Vorrichtung zur elektrischen Kontaktierung biologischer Zellen An apparatus for electrically contacting biological cells |
03/22/2012 | DE10036907B4 Verfahren zur Herstellung einer Beschichtung auf einem mit Gold bedampften Glassubstrat, Beschichtung hergestellt nach diesem Verfahren und deren Verwendung A process for producing a coating on a vapor-coated with gold glass substrate, the coating produced by this method and their use |
03/22/2012 | CA2811538A1 Na+/mg2+ exchanger |
03/22/2012 | CA2811501A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method |
03/22/2012 | CA2811107A1 Prolyl endopeptidase probes |
03/22/2012 | CA2811015A1 Molecular diagnostic test for cancer |
03/22/2012 | CA2811009A1 Raman spectroscopy for bioprocess operations |
03/22/2012 | CA2811003A1 A highly sensitive monoclonal antibody residual detection assay |
03/22/2012 | CA2810831A1 Method for non-invasive analysis of a substance concentration within a body |
03/22/2012 | CA2810778A1 Preparation of a molecular recognition element |
03/22/2012 | CA2810725A1 Methods of use and kit for measurement of lipopolysaccharide with a time resolved fluorescence based assay |
03/22/2012 | CA2810601A1 Analyte measurement method and system with hematocrit compensation |
03/22/2012 | CA2810568A1 Method for the diagnosis and/or prognosis of inflammatory states |
03/22/2012 | CA2810390A1 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid |
03/22/2012 | CA2810305A1 Electrical or electronic apparatus, in particular welding machine or battery charger |
03/22/2012 | CA2809877A1 Method and device for isolating cells from heterogeneous solution using microfluidic trapping vortices |
03/21/2012 | EP2431746A1 Platelet aggregation assays |
03/21/2012 | EP2431745A2 Method for using cfh or apoh as a biochemical marker for diagnosis of acute myeloid leukemia |
03/21/2012 | EP2431744A1 In vitro diagnostic method for infant eye allergy |
03/21/2012 | EP2431743A2 Cancer specific glycans and use thereof |
03/21/2012 | EP2431742A1 Preparation of a Molecular Recognition Element |
03/21/2012 | EP2431741A1 Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation) |
03/21/2012 | EP2431740A1 Method for measurement of equol in biological sample by immunoassay, kit for the measurement, and method for determination of equol production ability of subject |
03/21/2012 | EP2431739A1 Method for the detection and/or quantification of the interaction of platelets with interaction partners |
03/21/2012 | EP2431738A1 Method for screening osteopontin inhibitor and inhibitor prepared thereby |
03/21/2012 | EP2431730A1 Device for discriminating between different fluids based on their refractive index |
03/21/2012 | EP2431482A2 Anti-cancer drug screening method using ror |
03/21/2012 | EP2431480A2 Methods and compositions for increasing the stress resistance of cells and organisms |
03/21/2012 | EP2431478A1 Methods and compositions for expressing negative-sense viral RNA in canine cells |
03/21/2012 | EP2431463A1 Test agent for visceral obesity and use thereof |
03/21/2012 | EP2431460A2 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof |
03/21/2012 | EP2431391A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same |
03/21/2012 | EP2431387A1 A raft deficient yeast expression system for the production of recombinant membrane proteins |
03/21/2012 | EP2431377A1 Modified L-nucleic acids |
03/21/2012 | EP2431054A2 Human tumor necrosis factor delta and epsilon |
03/21/2012 | EP2431053A1 Novel glycosylated peptide target in neoplastic cells |
03/21/2012 | EP2431029A2 Method of inhibiting prostate cancer cell proliferation |
03/21/2012 | EP2430454A1 Imaging and evaluating embryos, oocytes, and stem cells |
03/21/2012 | EP2430453A1 Cmybp-c and mlc2 as diagnostic markers of cardiac injury |
03/21/2012 | EP2430452A1 Carcinoma diagnosis and treatments, based on odc1 genotype |
03/21/2012 | EP2430451A1 Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers |
03/21/2012 | EP2430450A1 Cybp as a marker of lung cancer |
03/21/2012 | EP2430449A1 Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer |
03/21/2012 | EP2430448A1 Detection of changes in cell populations and mixed cell populations |
03/21/2012 | EP2430447A1 Method for characterizing and/or determining samples |
03/21/2012 | EP2430446A2 Methods and compositions for analyte detection |
03/21/2012 | EP2430445A2 System and methods for rapid identification and/or characterization of a microbial agent in a sample |
03/21/2012 | EP2430444A1 Method for identifying inhibitors against dengue virus |
03/21/2012 | EP2430443A1 Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy |
03/21/2012 | EP2430442A1 Platform technologies for spontaneously occurring diseases |
03/21/2012 | EP2430440A1 Environmental control of fluid samples, calibration, and detection of concentration levels |
03/21/2012 | EP2430437A1 Apparatus and methods for separating and analyzing components in fluids |
03/21/2012 | EP2430430A1 Method for reducing loss of electromagnetic radiation in detection applications |
03/21/2012 | EP2430425A1 High sensitivity plasmonic structures for use in surface plasmon resonance sensors and method of fabrication thereof |
03/21/2012 | EP2430420A1 Closure, containing apparatus, and method of using same |
03/21/2012 | EP2430193A1 Markers for detection of gastric cancer |
03/21/2012 | EP2430191A1 Phosphodiesterase 4d7 as prostate cancer marker |
03/21/2012 | EP2430190A1 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer |
03/21/2012 | EP2430189A1 Phosphodiesterase 9a as prostate cancer marker |
03/21/2012 | EP2430179A1 Detection method |
03/21/2012 | EP2430178A1 Methods and kits for measuring toxicity and oxidative stress in live cells |
03/21/2012 | EP2430146A1 Method and apparatus for the analysis and identification of molecules |
03/21/2012 | EP2430049A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide |
03/21/2012 | EP2429957A1 Tagged scale inhibitors |
03/21/2012 | EP2429954A1 Real-time, on-line analysis for the quantification of total haloacetic acid and trihalomethane species in drinking water supplies |
03/21/2012 | EP2429712A1 Disposal separator/concentrator device and method of use |
03/21/2012 | EP2429565A2 Peptides and aptamers for targeting of neuron or nerves |
03/21/2012 | EP2329262B1 Filter system for extracorporeal depletion of activated polymorphonuclear leukocytes (pmns) |
03/21/2012 | EP2323764B1 Apparatus for effecting chemical assays |
03/21/2012 | EP2286238B1 Methods of distinguishing between glutamine formed by cataplerosis or proteolysis |
03/21/2012 | EP2176432B1 Diagnosing a disease and staging cancer by membrane electrophoresis |
03/21/2012 | EP2171450B1 Adamts4 as a blood biomarker and therapeutic target for chronic renal failure |
03/21/2012 | EP2167531B1 Streptococcus pneumoniae pilus antigens |
03/21/2012 | EP2148934B1 Matrix marker model and methods for assessing and treating rheumatoid arthritis |
03/21/2012 | EP2096432B1 Method for measuring 1,5-anhydroglucitol in whole blood |
03/21/2012 | EP2093194B1 Fluorescent labeling agent and fluorescent labeling method |
03/21/2012 | EP2044212B1 Methods for identifying patients with increased risk of an adverse cardiovascular event |
03/21/2012 | EP2023138B1 Method and system for screening the receptor-ligand binding in live cell |
03/21/2012 | EP1989551B1 Method of detecting or diagnosing of a neurodegenerative disease or condition |
03/21/2012 | EP1952142B1 Dissolution composition for examining drug solubility |
03/21/2012 | EP1889055B1 Test system |
03/21/2012 | EP1853629B1 Human ring specific bnp antibodies |
03/21/2012 | EP1825257B1 Diagnostic system for determining substance concentrations in liquid samples |